Terms: = Liver cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Diagnosis
27 results:
1. Placental metastasis from maternal NUT carcinoma: diagnostic pitfalls and challenges.
Lai JK; Panasci L; Patey NG; Wang H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569728
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of the first HBV qRT-PCR assay in the Mediterranean area targeting the X region.
Madihi S; Laassili C; Boukaira S; Baha W; Khyatti M; Zyad A; Ben Mkaddem S; Benani A
J Virol Methods; 2024 May; 326():114913. PubMed ID: 38452821
[TBL] [Abstract] [Full Text] [Related]
3. Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The liverKids: Study protocol.
Chacón C; Arteaga I; Martínez-Escudé A; Ruiz Rojano I; Lamonja-Vicente N; Caballeria L; Ribatallada Diez AM; Schröder H; Montraveta M; Bovo MV; Ginés P; Pera G; Diez-Fadrique G; Pachón-Camacho A; Alonso N; Graupera I; Torán-Monserrat P; Expósito C
PLoS One; 2023; 18(10):e0286586. PubMed ID: 37831682
[TBL] [Abstract] [Full Text] [Related]
4. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty liver Disease and Advanced liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.
Liu CF; Chien LW
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111111
[TBL] [Abstract] [Full Text] [Related]
5. Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis.
Macias J; Parra-Membrives P; Sosa-Moreno F; Rincon P; Martinez-Baena D; Fernandez-Fuertes M; Lorente-Herce JM; Martinez RC; Jimenez-Riera G; Corma-Gomez A; Gonzalez-Serna A; Pineda JA; Real LM
Sci Rep; 2022 Dec; 12(1):21897. PubMed ID: 36536019
[TBL] [Abstract] [Full Text] [Related]
6. Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma diagnosis Research.
Wang Y; Wei C; Deng X; Gao S; Chen J
Biomed Res Int; 2022; 2022():8365565. PubMed ID: 36193305
[TBL] [Abstract] [Full Text] [Related]
7. Transient Elastography and Serum-Based Tests for diagnosis of Fatty liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis.
Le MH; Henry L; Cheung R; Nguyen MH
Dig Dis; 2023; 41(5):767-779. PubMed ID: 35973400
[TBL] [Abstract] [Full Text] [Related]
8. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.
Zhang L; Zhang M; Wang M; Wang M; Zhang R; Wang H; Zhang W; Ding Y; Wang J
Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):865-872. PubMed ID: 35802528
[TBL] [Abstract] [Full Text] [Related]
9. Circular RNA as a Novel Biomarker and Therapeutic Target for HCC.
Meng H; Niu R; Huang C; Li J
Cells; 2022 Jun; 11(12):. PubMed ID: 35741077
[TBL] [Abstract] [Full Text] [Related]
10. The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.
Ding Y; Jiang L; Wang Q; Zhao W; Zhou X; Lu J; Tian T; Yu C; Xu X; Guo W; Zhang Q; Song C
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101951. PubMed ID: 35605893
[TBL] [Abstract] [Full Text] [Related]
11. Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.
Woreta TA; Van Natta ML; Lazo M; Krishnan A; Neuschwander-Tetri BA; Loomba R; Mae Diehl A; Abdelmalek MF; Chalasani N; Gawrieh S; Dasarathy S; Vuppalanchi R; Siddiqui MS; Kowdley KV; McCullough A; Terrault NA; Behling C; Kleiner DE; Fishbein M; Hertel P; Wilson LA; Mitchell EP; Miriel LA; Clark JM; Tonascia J; Sanyal AJ;
PLoS One; 2022; 17(4):e0266859. PubMed ID: 35427375
[TBL] [Abstract] [Full Text] [Related]
12. Association between bedtime at night and nonalcoholic fatty liver disease diagnosed by liver ultrasound transient elastography.
Zhou J; Long Y; Ding N; Su Y
Diabetes Res Clin Pract; 2022 Feb; 184():109195. PubMed ID: 35033597
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases.
Ni XX; Lian M; Wu HM; Li XY; Sheng L; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Hua J
World J Gastroenterol; 2021 Jan; 27(1):80-91. PubMed ID: 33505152
[TBL] [Abstract] [Full Text] [Related]
14. Primary intrapulmonary malignant peripheral nerve sheath tumor: A rare case.
Maane LA; Bouzidi AA; Damou M; Ismaili N
Cancer Treat Res Commun; 2020; 25():100243. PubMed ID: 33260029
[TBL] [Abstract] [Full Text] [Related]
15. Circular RNA is a popular molecule in tumors of the digestive system (Review).
Wang HY; Wang YP; Zeng X; Zheng Y; Guo QH; Ji R; Zhou YN
Int J Oncol; 2020 Jul; 57(1):21-42. PubMed ID: 32377736
[TBL] [Abstract] [Full Text] [Related]
16. Gadolinium-loaded calcium phosphate nanoparticles for magnetic resonance imaging of orthotopic hepatocarcinoma and primary hepatocellular carcinoma.
Zhang NN; Lu CY; Shu GF; Li J; Chen MJ; Chen CM; Lv XL; Xu XL; Weng W; Weng QY; Tang BF; Du YZ; Ji JS
Biomater Sci; 2020 Mar; 8(7):1961-1972. PubMed ID: 32064471
[TBL] [Abstract] [Full Text] [Related]
17. Haemorrhagic small bowel melanoma metastasis: a clinical rarity.
Zoumpos A; Ho NAH; Loeschhorn-Becker R; Schuppert F
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31511264
[TBL] [Abstract] [Full Text] [Related]
18. Dilemmas in diagnosis and Management of Gastroenteropancreatic Mixed Neuroendocrine Non-neuroendocrine Neoplasms: First Single-Centre Report from India.
Desai GS; Pande P; Shah RC; Jagannath P
J Gastrointest Cancer; 2020 Mar; 51(1):102-108. PubMed ID: 30784017
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty liver Disease (NAFLD): Results From the ECHAM Study.
Lemoine M; Assoumou L; De Wit S; Girard PM; Valantin MA; Katlama C; Necsoi C; Campa P; Huefner AD; Schulze Zur Wiesch J; Rougier H; Bastard JP; Stocker H; Mauss S; Serfaty L; Ratziu V; Menu Y; Schlue J; Behrens G; Bedossa P; Capeau J; Ingiliz P; Costagliola D;
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e86-e94. PubMed ID: 30570529
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
Abdelaziz AO; Shousha HI; Said EM; Soliman ZA; Shehata AA; Nabil MM; Abdelmaksoud AH; Elbaz TM; Abdelsalam FM
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1384-1388. PubMed ID: 30179227
[TBL] [Abstract] [Full Text] [Related]
[Next]
